Unknown NA INTERVENTIONAL 2-arm NCT01553435

Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients

Sponsor: King Abdullah International Medical Research Center

Conditions Analgesia Tolerance Opioid Tolerance Pain

Updated 6 times since 2017 Last updated: Apr 12, 2015 Started: Jan 31, 2011 Primary completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01553435, this NA trial focuses on Analgesia Tolerance and Opioid Tolerance and remains ongoing. Sponsored by King Abdullah International Medical Research Center, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
May 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Active Not Recruiting NA

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

King Abdullah International Medical Research Center

Data source: King Abdullah International Medical Research Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Riyadh, Saudi Arabia